OIG Report: CMS Still Covering ‘Terminated’ Drugs in Medicare Part D

Drug Industry Daily
A A
CMS allows Medicare Part D to cover “terminated” drugs that have run out their shelf lives or been withdrawn from the market, says HHS’s Office of Inspector General.

To View This Article:

Login

Subscribe To Drug Industry Daily